Replimune Group Inc (NASDAQ: REPL) is -10.65% lower on its value in year-to-date trading and has touched a low of $4.92 and a high of $17.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The REPL stock was last observed hovering at around $11.60 in the last trading session, with the day’s loss setting it -0.78%.
Currently trading at $10.82, the stock is -10.08% and -14.31% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.0 million and changing -6.72% at the moment leaves the stock -3.97% off its SMA200. REPL registered 30.99% gain for a year compared to 6-month gain of -2.35%. The firm has a 50-day simple moving average (SMA 50) of $12.6274 and a 200-day simple moving average (SMA200) of $11.267375.
The stock witnessed a -24.39% loss in the last 1 month and extending the period to 3 months gives it a -7.68%, and is -7.16% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.43% over the week and 6.75% over the month.
Replimune Group Inc (REPL) has around 331 employees, a market worth around $833.30M and $0.00M in sales. Distance from 52-week low is 119.92% and -36.35% from its 52-week high. The company has generated returns on investments over the last 12 months (-41.16%).
The EPS is expected to grow by 11.67% this year.
Replimune Group Inc (REPL) Top Institutional Holders
221.0 institutions hold shares in Replimune Group Inc (REPL), with institutional investors hold 106.37% of the company’s shares. The shares outstanding are 77.01M, and float is at 61.87M with Short Float at 14.78%. Institutions hold 101.93% of the Float.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 10.05 million shares valued at $90.41 million. The investor’s holdings represent 14.5193% of the REPL Shares outstanding. As of 2024-06-30, the second largest holder is PRICE T ROWE ASSOCIATES INC /MD/ with 9.24 million shares valued at $83.13 million to account for 13.8742 of the shares outstanding. The other top investors are REDMILE GROUP, LLC which holds 5.56 million shares representing 8.0394% and valued at over $50.06 million, while BLACKROCK INC. holds 7.081 of the shares totaling 4.71 million with a market value of $42.42 million.
Replimune Group Inc (REPL) Insider Activity
The most recent transaction is an insider sale by Patel Sushil, the company’s Chief Executive Officer. SEC filings show that Patel Sushil sold 10,000 shares of the company’s common stock on Dec 16 ’24 at a price of $12.42 per share for a total of $0.12 million. Following the sale, the insider now owns 0.2 million shares.
Still, SEC filings show that on Nov 18 ’24, Xynos Konstantinos (Chief Medical Officer) disposed off 7,246 shares at an average price of $10.78 for $78112.0. The insider now directly holds 109,885 shares of Replimune Group Inc (REPL).
